Mark E. Bunnage - EVP, Chief Scientific Officer at VERTEX PHARMACEUTICALS INC / MA

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, Chief Scientific Officer
Issuer Symbol
VRTX on Nasdaq
All Insider Reports
All Insider Reports

Mark E. Bunnage - trading volume in the past year for VERTEX PHARMACEUTICALS INC / MA

Holdings reported by Mark E. Bunnage for VERTEX PHARMACEUTICALS INC / MA

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 12,914 $5,945,993 $460.43 11 Feb 2026 Direct

Transactions reported by Mark E. Bunnage for VERTEX PHARMACEUTICALS INC / MA

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.